# Starling Oncology, Inc.: Form 8-K, filed Nov 14, 2025

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: 8-K
- Filed: 2025-11-14
- Accepted by EDGAR: Nov 14, 2025, 06:18 ET
- Period: 2025-11-14
- Accession: 0001079973-25-001724
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000107997325001724/toi_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000107997325001724/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000107997325001724/toi_8k.htm

Filed Nov 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001079973-25-001724. Last ingested by Listed: Nov 15, 2026, 04:34 ET. No prices; not investment advice.
